Pharmaceutical sector analysis and M&A valuation models : the Allegan INC's acquisition
Ver/ Abrir
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/158176
comunitat-uji-handle2:10234/71324
comunitat-uji-handle3:10234/97664
comunitat-uji-handle4:
TFG-TFMEste recurso está restringido
Metadatos
Título
Pharmaceutical sector analysis and M&A valuation models : the Allegan INC's acquisitionAutoría
Tutor/Supervisor
Maset Llaudes, AmparoTutor/Supervisor; Universidad.Departamento
Universitat Jaume I. Departament de Finances i ComptabilitatFecha de publicación
2016-07-20Editor
Universitat Jaume IResumen
Corporate restructuring activities are a big part of the corporate finance
world, especially in the Pharmaceutical sector, which has experienced a
wide wave of corporate Merger and Acquisition activities in the ... [+]
Corporate restructuring activities are a big part of the corporate finance
world, especially in the Pharmaceutical sector, which has experienced a
wide wave of corporate Merger and Acquisition activities in the last
years. This paper provides a generally analysis of the Pharmaceutical
sector and explain the main issues and challenges of the industry in the
last two years. For this, a specific analysis by periods of time, by region
(USA and Europe) and a comparison of different companies are
provided. The most important contribution of this paper is the analysis of
specific M&A transactions in which it has been obtained insights about
the valuation of the target companies, deal drivers, and synergies in the
Pharmaceutical industry. [-]
Palabras clave / Materias
Descripción
Treball Final de Grau en Finances i Comptabilitat. Codi: FC1049. Curs: 2015/2016
Tipo de documento
info:eu-repo/semantics/bachelorThesisDerechos de acceso
http://rightsstatements.org/vocab/CNE/1.0/
info:eu-repo/semantics/restrictedAccess
info:eu-repo/semantics/restrictedAccess